Roivant Sciences Ltd. 4

Non-employee director Melissa B. Epperly had 2,179 Roivant Sciences Ltd. common shares withheld in a tax-related net settlement upon vesting of prior equity awards, leaving her with 14,838 shares owned directly.

On 2026-09-10, Melissa B. Epperly, a non-employee director of Roivant Sciences Ltd., had 2,179 common shares withheld by the company at a reference price of approximately $40.94 per share in a net-share settlement related to the vesting of previously granted director equity awards, solely to satisfy tax withholding obligations. This Form 4 reflects a routine compensation-related share withholding (coded as transaction type “F”), leaving her with direct ownership of 14,838 common shares after the transaction. No open-market purchase or sale was executed; instead, part of the vested shares were retained by the issuer to cover taxes, resulting in an implied transaction value of roughly $89,000. The remaining directly held shares are valued at about $607,000 based on the same price reference.

Filing Facts

CIK

1635088

Ticker

ROIV

Form

4

Source Type

fda

Accession

0001807359-26-000012

Alert Tier

4